Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.50) per share and revenue of $1.15 million for the quarter. Parties interested in listening to the company’s conference call can do so using this link.
Arcadia Biosciences Trading Up 3.9 %
Shares of NASDAQ RKDA opened at $3.43 on Thursday. Arcadia Biosciences has a twelve month low of $1.85 and a twelve month high of $10.31. The stock has a 50 day moving average of $4.40 and a two-hundred day moving average of $4.10. The stock has a market cap of $4.68 million, a P/E ratio of -0.80 and a beta of 0.86.
Analyst Upgrades and Downgrades
Separately, StockNews.com started coverage on Arcadia Biosciences in a report on Saturday, March 15th. They issued a “sell” rating on the stock.
About Arcadia Biosciences
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Featured Articles
- Five stocks we like better than Arcadia Biosciences
- How to Use the MarketBeat Dividend Calculator
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Overbought Stocks Explained: Should You Trade Them?
- Alphabet’s Officially In A Bear Market—Time To Buy?
- What is MarketRank™? How to Use it
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.